BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Melo LT, Duailibe MAB, Pessoa LM, da Costa FN, Vieira-neto AE, de Vasconcellos Abdon AP, Campos AR. (−)-α-Bisabolol reduces orofacial nociceptive behavior in rodents. Naunyn-Schmiedeberg's Arch Pharmacol 2017;390:187-95. [DOI: 10.1007/s00210-016-1319-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Eddin LB, Jha NK, Goyal SN, Agrawal YO, Subramanya SB, Bastaki SMA, Ojha S. Health Benefits, Pharmacological Effects, Molecular Mechanisms, and Therapeutic Potential of α-Bisabolol. Nutrients 2022;14:1370. [PMID: 35405982 DOI: 10.3390/nu14071370] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Li Y, Yang C, Shen Q, Peng Q, Guo Q, Nie Z, Sun X, Shi T, Ji X, Huang H. YALIcloneNHEJ: An Efficient Modular Cloning Toolkit for NHEJ Integration of Multigene Pathway and Terpenoid Production in Yarrowia lipolytica. Front Bioeng Biotechnol 2022;9:816980. [DOI: 10.3389/fbioe.2021.816980] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Liktor-Busa E, Keresztes A, LaVigne J, Streicher JM, Largent-Milnes TM. Analgesic Potential of Terpenes Derived from Cannabis sativa. Pharmacol Rev 2021;73:98-126. [PMID: 34663685 DOI: 10.1124/pharmrev.120.000046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
4 Yang B, Ma S, Zhang C, Sun J, Zhang D, Chang S, Lin Y, Zhao G. Higenamine Attenuates Neuropathic Pain by Inhibition of NOX2/ROS/TRP/P38 Mitogen-Activated Protein Kinase/NF-ĸB Signaling Pathway. Front Pharmacol 2021;12:716684. [PMID: 34630095 DOI: 10.3389/fphar.2021.716684] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
5 Ortiz MI, Cariño-Cortés R, Muñoz-Pérez VM, Salas-Casas A, Castañeda-Hernández G. Role of the NO-cGMP-K+ channels pathway in the peripheral antinociception induced by α-bisabolol. Can J Physiol Pharmacol 2021;:1-9. [PMID: 33857384 DOI: 10.1139/cjpp-2020-0744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wu M, Cai J, Yu Y, Hu S, Wang Y, Wu M. Therapeutic Agents for the Treatment of Temporomandibular Joint Disorders: Progress and Perspective. Front Pharmacol 2020;11:596099. [PMID: 33584275 DOI: 10.3389/fphar.2020.596099] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
7 Oliveira JP, Nampo FK, Souza MTS, Cercato LM, Camargo EA. The effect of natural products in animal models of temporomandibular disorders. J Appl Oral Sci 2020;28:e20200272. [PMID: 32725048 DOI: 10.1590/1678-7757-2020-0272] [Reference Citation Analysis]
8 Oliveira JP, Souza MTS, Cercato LM, Souza AW, Nampo FK, Camargo EA. Natural products for orofacial nociception in pre-clinical studies: A systematic review. Arch Oral Biol 2020;117:104748. [PMID: 32599517 DOI: 10.1016/j.archoralbio.2020.104748] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Assis DB, Aragão Neto HC, da Fonsêca DV, de Andrade HHN, Braga RM, Badr N, Maia MDS, Castro RD, Scotti L, Scotti MT, de Almeida RN. Antinociceptive Activity of Chemical Components of Essential Oils That Involves Docking Studies: A Review. Front Pharmacol 2020;11:777. [PMID: 32547391 DOI: 10.3389/fphar.2020.00777] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
10 Bodnar RJ. Endogenous opiates and behavior: 2017. Peptides 2020;124:170223. [DOI: 10.1016/j.peptides.2019.170223] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
11 Fontinele LL, Heimfarth L, Pereira EWM, Rezende MM, Lima NT, Barbosa Gomes de Carvalho YM, Afonso de Moura Pires E, Guimarães AG, Bezerra Carvalho MT, de Souza Siqueira Barreto R, Campos AR, Antoniolli AR, Antunes de Souza Araújo A, Quintans-Júnior LJ, de Souza Siqueira Quintans J. Anti-hyperalgesic effect of (-)-α-bisabolol and (-)-α-bisabolol/β-Cyclodextrin complex in a chronic inflammatory pain model is associated with reduced reactive gliosis and cytokine modulation. Neurochem Int 2019;131:104530. [PMID: 31425746 DOI: 10.1016/j.neuint.2019.104530] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
12 Melo LT, Panchalingam V, Cherkas P, Campos AR, Avivi-Arber L, Sessle BJ. (-)-α-Bisabolol reduces nociception and trigeminal central sensitisation in acute orofacial neuropathic pain induced by infraorbital nerve injury. Life Sci 2019;227:122-8. [PMID: 31002923 DOI: 10.1016/j.lfs.2019.04.032] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
13 Leite LHI, Leite GO, da Silva BAF, Santos SAA, Magalhães FEA, Menezes PP, Serafini MR, Teixeira CS, Brito RG, Santos PL, da Costa JGM, Araújo AA, Quintans-júnior LJ, de Menezes IR, Coutinho HDM, Campos AR. Molecular mechanism underlying orofacial antinociceptive activity of Vanillosmopsis arborea Baker (Asteraceae) essential oil complexed with β-cyclodextrin. Phytomedicine 2019;55:293-301. [DOI: 10.1016/j.phymed.2018.09.173] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
14 Nuutinen T. Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus. Eur J Med Chem 2018;157:198-228. [PMID: 30096653 DOI: 10.1016/j.ejmech.2018.07.076] [Cited by in Crossref: 112] [Cited by in F6Publishing: 121] [Article Influence: 28.0] [Reference Citation Analysis]
15 Amora-silva BF, Ribeiro SC, Vieira CL, Mendes FR, Vieira-neto AE, Abdon APV, Costa FN, Campos AR. Clinical efficacy of new α-bisabolol mouthwashes in postoperative complications of maxillofacial surgeries: a randomized, controlled, triple-blind clinical trial. Clin Oral Invest 2019;23:577-84. [DOI: 10.1007/s00784-018-2464-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Teixeira GFD, Vieira-neto AE, da Costa FN, e Silva ARA, Campos AR. Antinociceptive effect of (-)-α-bisabolol in nanocapsules. Biomedicine & Pharmacotherapy 2017;91:946-50. [DOI: 10.1016/j.biopha.2017.05.024] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]